Description
PT-141 Bremelanotide 10mg Research Peptide
PT-141 Bremelanotide 10mg is a synthetic melanocortin peptide supplied in lyophilised form for controlled scientific and laboratory research. Each vial provides a clearly identified 10mg quantity of PT-141 (Bremelanotide) for experimental investigations involving melanocortin receptors and related signalling pathways.
Unlike peptides primarily investigated through growth hormone-related mechanisms, Bremelanotide is associated with the melanocortin receptor system. This distinctive mechanism has made PT-141 an established subject of pharmacological and biological research.
This product is supplied strictly as a research peptide. It is not intended for human consumption, self-administration or therapeutic use.
PT-141 10mg Product Specifications
- Product Name: PT-141
- Alternative Name: Bremelanotide
- Strength: 10mg per vial
- Form: Lyophilised peptide
- Peptide Class: Melanocortin peptide
- Product Type: Research material
- Application: Laboratory and scientific research
- Human Use: Not intended for human consumption
What Is PT-141 (Bremelanotide)?
PT-141, commonly known as Bremelanotide, is a synthetic peptide associated with the melanocortin family of signalling compounds.
Its scientific significance comes primarily from its interaction with melanocortin receptors. These receptors participate in several biological signalling systems and have consequently been investigated extensively in pharmacological research.
PT-141 differs mechanistically from many other research peptides. Rather than being primarily associated with growth hormone or IGF signalling, Bremelanotide research focuses on the melanocortin receptor pathway.
What Is PT-141 Studied For?
PT-141 has been investigated in scientific and pharmacological research involving melanocortin signalling and receptor activity.
Depending on the experimental model and research objective, researchers may encounter Bremelanotide in studies involving:
- Melanocortin receptor signalling
- Melanocortin receptor activation
- Peptide-receptor interactions
- Central nervous system signalling
- Behavioural pharmacology
- Neuroendocrine pathways
- Experimental peptide pharmacology
These areas describe scientific research interests rather than claims regarding the effects of this particular research product.
PT-141 and Melanocortin Receptor Research
The melanocortin system consists of receptors and signalling molecules involved in multiple biological processes. PT-141 has attracted research attention because of its pharmacological interaction with particular melanocortin receptors.
This gives researchers an opportunity to investigate receptor activation and downstream signalling under controlled experimental conditions.
Experimental findings involving Bremelanotide should always be evaluated according to the methodology, research model, concentration and limitations of the individual study.
Bremelanotide in Pharmaceutical Research
Bremelanotide is unusual among research peptides because a prescription form of the active compound has undergone formal pharmaceutical development and regulatory review for a specific medical indication.
That does not mean every product labelled PT-141 or Bremelanotide is equivalent to an approved medicine. A PT-141 research peptide and a regulated prescription pharmaceutical should not be treated as interchangeable products.
The PT-141 10mg product described on this page is supplied specifically for laboratory research and should not be represented as a prescription medicine or substitute for one.
Why Peptide Identity and Documentation Matter
Reliable scientific research depends on clearly characterised experimental materials. Product identity, batch consistency, storage and analytical documentation can all affect the reproducibility and interpretation of peptide research.
When evaluating PT-141 10mg for laboratory applications, relevant information can include:
- Clearly stated peptide identity
- Defined quantity per vial
- Batch or lot identification
- Analytical testing documentation
- Appropriate packaging
- Storage information
- Certificate of Analysis (COA), where available
Any purity percentage advertised for a specific PT-141 batch should be supported by appropriate analytical testing rather than presented as an unsupported generic claim.
Lyophilised PT-141 10mg
Our PT-141 Bremelanotide 10mg research peptide is supplied in lyophilised form. This format is commonly used when preparing peptide materials for suitable laboratory storage and research handling.
Each vial is clearly identified as containing 10mg of PT-141. Researchers should consult the relevant product or batch documentation and follow established laboratory procedures when handling or storing the material.
PT-141 10mg for UK Research
Researchers sourcing PT-141 10mg in the UK should consider accurate product identification, transparent specifications and supporting analytical information when evaluating laboratory materials.
Clear documentation helps distinguish legitimate research information from exaggerated claims sometimes associated with peptides online.
This PT-141 product is therefore presented according to its intended purpose: a synthetic research peptide for controlled laboratory investigation.
Important Research-Use Information
Information concerning prescription Bremelanotide or results reported in published studies should not automatically be interpreted as evidence about a separately manufactured research peptide.
PT-141 Bremelanotide 10mg is supplied exclusively for laboratory, analytical and scientific research.
This research product is not intended for human consumption, self-administration, diagnosis, treatment, prevention or cure of any disease or medical condition.
Frequently Asked Questions About PT-141 Bremelanotide
What is PT-141?
PT-141 is another name commonly used for Bremelanotide, a synthetic melanocortin peptide investigated for its interaction with melanocortin receptor pathways.
Is PT-141 the same as Bremelanotide?
PT-141 is commonly used as a research name for Bremelanotide. However, a laboratory research product should not be assumed to be interchangeable with an authorised pharmaceutical product containing Bremelanotide.
How much PT-141 is contained in each vial?
Each vial contains 10mg of PT-141 (Bremelanotide).
What type of peptide is PT-141?
PT-141 is a synthetic peptide associated with the melanocortin receptor system and is studied experimentally for its interaction with melanocortin signalling pathways.
What is PT-141 researched for?
PT-141 appears in scientific research involving melanocortin receptor activity, receptor signalling, neuroendocrine pathways and related areas of experimental pharmacology.
Is PT-141 a growth hormone peptide?
No. PT-141 is not primarily classified as a growth hormone-releasing peptide. Its principal research mechanism involves the melanocortin receptor system.
What form does PT-141 10mg come in?
This PT-141 10mg research product is supplied in lyophilised form for appropriate laboratory applications.
How should PT-141 10mg be stored?
Researchers should follow the storage requirements specified in the documentation accompanying the particular product or batch and use appropriate laboratory storage procedures.
Is this PT-141 intended for human use?
No. This PT-141 Bremelanotide 10mg research peptide is intended exclusively for scientific and laboratory research and is not intended for human consumption or self-administration.
PT-141 Bremelanotide 10mg for Laboratory Research
PT-141 Bremelanotide 10mg provides researchers with a clearly identified quantity of synthetic PT-141 in lyophilised form for appropriate scientific and laboratory applications.
Researchers should review available product specifications, batch information and analytical documentation before beginning experimental work.
For research use only. Not intended for human consumption, self-administration or therapeutic use.
Reviews
There are no reviews yet.